Best hospitals in the world 2020

For the second year in a row, Newsweek has ranked the best hospitals in the world in partnership with global research company Statista.

The list covers the leading hospitals across 21 countries, overseen by a board of global experts that acts as an independent body to develop the quality and scope of the project.

The rankings take several considerations under review, including recommendations from medical professionals, patient survey results and medical performance indicators. Tens of thousands of medical professionals in the 21 selected countries were invited to complete an online survey from September to November 2019.

The United States had the most top hospitals of the measured countries, with 300.

Here are the top 10 best hospitals in 2020 as ranked by Newsweek:

  1. Mayo Clinic-Rochester, USA
  2. Cleveland Clinic, USA
  3. Massachusetts General Hospital, USA
  4. Toronto General (University Health Network), Canada
  5. Charité-Universitätsmedizin Berlin, Germany
  6. The John Hopkins Hospital, USA
  7. Universitätsspital Zürich, Switzerland
  8. Singapore General Hospital, Singapore
  9. Sheba Medical Center, Israel
  10. Karolinska Universitetssjukhuset, Sweden

See the full list here.

 

Related Top Ranked Hospitals Content:

33 U.S. hospitals are among the best in the world

48 hospitals make Forbes’ list of best employers

Meet the 10 best hospitals in the world

Best of the best? Meet the world’s top 250 hospitals for cardiology

Wide variation in musculoskeletal imaging charges, including 74-fold difference for one CT exam

Only 21% of U.S. hospitals comply with price transparency mandate for shopable imaging exams

 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.